Inhibition of SHP2 enhances the effects of selective receptor tyrosine kinase inhibitors in untreated preclinical models of RET-mutated thyroid cancer.
- DOI
- 10.1007/s10637-026-01633-z
- Published
- 2026 Aug 27
- Container
- Investigational new drugs
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10637-026-01633-z,
title = {Inhibition of SHP2 enhances the effects of selective receptor tyrosine kinase inhibitors in untreated preclinical models of RET-mutated thyroid cancer.},
author = {Xie W and Tian M and Ma W and Sun Y and Hu L and Zeng Y and Chen X and Ruan X and Zheng X and Gao M},
year = {2026},
journal = {Investigational new drugs},
doi = {10.1007/s10637-026-01633-z},
url = {https://doi.org/10.1007/s10637-026-01633-z}
}RIS
TY - JOUR TI - Inhibition of SHP2 enhances the effects of selective receptor tyrosine kinase inhibitors in untreated preclinical models of RET-mutated thyroid cancer. AU - Xie W AU - Tian M AU - Ma W AU - Sun Y AU - Hu L AU - Zeng Y AU - Chen X AU - Ruan X AU - Zheng X AU - Gao M PY - 2026 JO - Investigational new drugs DO - 10.1007/s10637-026-01633-z UR - https://doi.org/10.1007/s10637-026-01633-z ER -
APA
W, X., M, T., W, M., Y, S., L, H., Y, Z., X, C., X, R., X, Z., & M, G. (2026). Inhibition of SHP2 enhances the effects of selective receptor tyrosine kinase inhibitors in untreated preclinical models of RET-mutated thyroid cancer.. Investigational new drugs. https://doi.org/10.1007/s10637-026-01633-z
Source records
- pubmed · retrieved 2026-09-27T01:27:15.316Z
- europe-pmc · retrieved 2026-09-27T01:27:15.324Z